Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Illumina Names Daniel Grosu CMO; GeneNews Taps Karl Wassmann


Illumina said this week that it has appointed Daniel Grosu as Chief Medical Officer, a newly created position at the company.

Grosu will play a key role in building Illumina’s diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina’s CLIA-certified clinical laboratory, the company said.

Prior to joining Illumina, Grosu was group director of clinical science and clinical and medical affairs at Ortho-Clinical Diagnostics. He was also previously the director and leader of global clinical development and diagnostic imaging at Bayer Healthcare Pharmaceuticals. Grosu has also worked for Siemens Medical Solutions. He holds a BS and MS degree from Wheaton College; an MD from Saint Louis University; and an MBA from the University of Oxford.

GeneNews said this week that it has appointed Karl Wassmann to the newly created position of executive vice president of US corporate development.

In his new role, Wassmann will manage GeneNews' SentinelGx services. Most recently he served as president and CEO of Source MDx, a privately-held U.S. company focused on the development of whole blood and rare cell-based inflammation and oncology biomarkers for laboratory developed tests and companion diagnostics. Wassmann has led more than 30 biomarker and companion diagnostic prospective clinical development programs totaling over 7,000 patients in collaboration with leading pharmaceutical companies and major academic medical centers, GeneNews said. He holds an MBA from the University of Chicago's Booth School of Business.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.